Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Prager

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Diabetes Care|June 28, 2006
Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetesBarbara Kollerits, Martin Auinger, Veronika Reisig, et al.
Acta Medica Austriaca|March 8, 2005
[Therapy with insulin]Alexandra Kautzky-Willer, Monika Lechleitner, Thomas R Pieber, et al.
Acta Medica Austriaca|March 8, 2005
[Therapy with oral antidiabetic drugs]Alexandra Kautzky-Willer, Monika Lechleitner, Thomas R Pieber, et al.
Current Medical Research and Opinion|June 23, 2020
Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT studyDeborah R Leitner, Hermann Toplak, Ludmilla Kedenko, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric bandingUrsula Hanusch-Enserer, Edmund Cauza, Georg Brabant, et al.
Wiener Klinische Wochenschrift|December 20, 2012
[CGM-continuous glucose monitoring - statement of the Austrian Diabetes Association]Ingrid Schütz-Fuhrmann, Edith Schober, Birgit Rami, et al.
Diabetes, Obesity & Metabolism|November 7, 2017
A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetesThorsten Siegmund, Nikolaos Tentolouris, Søren T Knudsen, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
NT-proBNP and cardiac events in older diabetic patientsMichael Resl, Stephanie Neuhold, Michaela Riedl, et al.
European Journal of Clinical Investigation|May 28, 2011
Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitusStephanie Neuhold, Michael Resl, Martin Huelsmann, et al.
Clinical Chemistry|November 20, 2004
N-terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failureKatharina-Maria Hermann-Arnhof, Ursula Hanusch-Enserer, Thomas Kaestenbauer, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Diabetes Care|June 28, 2006
Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetesBarbara Kollerits, Martin Auinger, Veronika Reisig, et al.
Acta Medica Austriaca|March 8, 2005
[Therapy with insulin]Alexandra Kautzky-Willer, Monika Lechleitner, Thomas R Pieber, et al.
Acta Medica Austriaca|March 8, 2005
[Therapy with oral antidiabetic drugs]Alexandra Kautzky-Willer, Monika Lechleitner, Thomas R Pieber, et al.
Current Medical Research and Opinion|June 23, 2020
Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT studyDeborah R Leitner, Hermann Toplak, Ludmilla Kedenko, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric bandingUrsula Hanusch-Enserer, Edmund Cauza, Georg Brabant, et al.
Wiener Klinische Wochenschrift|December 20, 2012
[CGM-continuous glucose monitoring - statement of the Austrian Diabetes Association]Ingrid Schütz-Fuhrmann, Edith Schober, Birgit Rami, et al.
Diabetes, Obesity & Metabolism|November 7, 2017
A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetesThorsten Siegmund, Nikolaos Tentolouris, Søren T Knudsen, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
NT-proBNP and cardiac events in older diabetic patientsMichael Resl, Stephanie Neuhold, Michaela Riedl, et al.
European Journal of Clinical Investigation|May 28, 2011
Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitusStephanie Neuhold, Michael Resl, Martin Huelsmann, et al.
Clinical Chemistry|November 20, 2004
N-terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failureKatharina-Maria Hermann-Arnhof, Ursula Hanusch-Enserer, Thomas Kaestenbauer, et al.
Pageof 7